Skip to main navigation Skip to search Skip to main content

The role of molecular imaging biomarkers in oncology clinical trials - Targeting the hallmarks of cancer

Research output: Contribution to journal › Review article › peer-review

Original languageEnglish (US)
Pages (from-to)69-75
Number of pages7
JournalAmerican Pharmaceutical Review
Volume12
Issue number5
StatePublished - Jul 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this